Research Summary

Robert Raphael, MD is a Clinical Professor of Pediatrics at UCSF in the Division of Pediatric Oncology. Based at Benioff Children's Hospital Oakland, his primary focus is clinical care for children with cancer, including particular interests in lymphomas, histiocyte disorders, and survivorship. Dr. Raphael is the Medical Director of the Survivorship Program at UCSF BCH-Oakland. He also serves as Associate Director of the BCH-Oakland Pediatric Hematology-Oncology Fellowship Program.

Dr. Raphael is a member of the American Society of Pediatric Hematology/Oncology, Children's Oncology Group and the North American Consortium for Histiocytosis.


06/2007 - Pediatric Hematology-Oncology, Children's Hospital & Research Center Oakland Pediatric Hematology-Oncology Fellowship Program
06/2004 - Pediatrics, UCSD Pediatrics Residency Program
MD, 06/2001 - , UCSD School of Medicine
BA, 05/1996 - Anthropology, University of Pennsylvania

Honors & Awards

  • 1996
    Phi Beta Kappa, Delta Chapter, University of Pennsylvania
  • 2001
    Fretom Fund Award for outstanding clinical skills, UCSD School of Medicine
  • 2001
    S.B. Hamburger Memorial Thesis Award, UCSD School of Medicine
  • 2001
    MAGIC Award for patient care, Children’s Hospital San Diego
  • 2004
    AAP Resident of the Month Award for May, 2004, Children’s Hospital, San Diego
  • 2005, 2007, 2015
    Stars for Kids Award for patient care, Children’s Hospital Oakland

Selected Publications

  1. Mosher N, Torkildson J, Golden C, Raphael R, Beach B, Michlitsch J, Feusner JH, Agrawal AK. Utilization of Thiopurine Metabolites and Allopurinol in Pediatric Acute Lymphoblastic Leukemia: Consideration for an Algorithmic Approach. J Pediatr Hematol Oncol. 2022 Mar 01; 44(2):e521-e525.  View on PubMed
  2. Agrawal AK, Michlitsch J, Golden C, Hastings CA, Raphael R, Feusner JH. Nelarabine in Pediatric and Young Adult T-Cell Acute Lymphoblastic Leukemia-Clearly Beneficial? J Clin Oncol. 2021 02 20; 39(6):694.  View on PubMed
  3. Raphael RI. Pathophysiology and treatment of sickle cell disease. Clin Adv Hematol Oncol. 2005 Jun; 3(6):492-505.  View on PubMed

Go to UCSF Profiles, powered by CTSI